VS
stockvs
Go to ScreenerHub
ABBV

ABBV vs PFE

PFE

In the past 12 months, ABBV returned +3% while PFE gained 2%.

ABBV
ABBV

AbbVie Inc.

$221.45
-4.9%(1M)
Market Cap391.6B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio95.64
ROE-3.6%
P/B Ratio-123.60
Dividend Yield2.9%
PFE
PFE

Pfizer Inc.

$26.61
-2.8%(1M)
Market Cap151.3B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio19.86
ROE8.7%
P/B Ratio1.78
Dividend Yield6.3%
Performance Comparison

Historical returns across multiple timeframes

ABBV

ABBV

AbbVie Inc.

+3.3%

1Y Return

PFE

PFE

Pfizer Inc.

+2.1%

1Y Return

ABBV
ABBV
PFE
PFE

Short Term

1M-6M

PFE
+4.3%

Medium Term

YTD-1Y

PFE
+3.9%

Long Term

3Y-10Y

ABBV
+145.2%

Valuation

Compare price multiples and valuation ratios

ABBV: 1PFE: 4
MetricABBVPFEWinner
P/E Ratio

Price to earnings ratio

95.6419.86PFE
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

6.562.47PFE
P/B Ratio

Price to book ratio

-123.601.78ABBV
P/FCF Ratio

Price to free cash flow ratio

21.4617.02PFE
EV/EBITDA

Enterprise value to EBITDA

16.4113.16PFE
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

ABBV: 3PFE: 3
MetricABBVPFEWinner
Gross Margin

Gross profit margin

73.3%70.3%ABBV
Operating Margin

Operating profit margin

26.7%24.7%ABBV
Net Margin

Net profit margin

6.9%12.4%PFE
ROE

Return on equity

-3.6%8.7%PFE
ROA

Return on assets

3.2%3.7%PFE
ROIC

Return on invested capital

10.6%8.8%ABBV

Growth

Compare revenue and earnings growth rates

ABBV: 5PFE: 1
MetricABBVPFEWinner
Revenue Growth (YoY)

Year-over-year revenue growth

8.6%-1.6%ABBV
Revenue Growth (3Y)

3-year revenue CAGR

1.8%-14.6%ABBV
Revenue Growth (5Y)

5-year revenue CAGR

6.0%8.5%PFE
EPS Growth (YoY)

Year-over-year EPS growth

-1.3%-3.5%ABBV
EPS Growth (3Y)

3-year EPS CAGR

-29.1%-37.1%ABBV
EPS Growth (5Y)

5-year EPS CAGR

-2.8%-3.5%ABBV

Balance Sheet & Risk

Compare financial stability and debt levels

ABBV: 2PFE: 3
MetricABBVPFEWinner
Debt/Equity

Debt to equity ratio

-21.060.78ABBV
Current Ratio

Current assets to current liabilities

0.671.16PFE
Quick Ratio

Quick assets to current liabilities

0.560.87PFE
Interest Coverage

EBIT to interest expense

5.775.78PFE
Beta

Stock volatility vs market

0.330.41ABBV
Summary
PFE wins 2-1

Valuation

PFE

Profitability

Tie

Growth

ABBV

Balance Sheet

PFE

PFE is more attractively valued. ABBV demonstrates better growth. PFE has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into ABBV and PFE with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/ABBV/vs/PFE" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare ABBV vs PFE on stockvs.app
</a>